When indicated, laboratory markers such as blood sugar trends, insulin sensitivity, or metabolic parameters may be reviewed to ensure the medication is supporting overall health
All eight reported studies have demonstrated the noninferiority of GLP-1RAs compared to placebo regarding MACE
GLP-1's primary functions include: Enhancing insulin secretion in response to glucose Suppressing inappropriate glucagon release Delaying gastric emptying Promoting satiety and reducing appetite Understanding GLP-1's role is fundamental when evaluating whether dietary interventions, such as allulose consumption, might influence incretin hormone activity or complement GLP-1-based therapies
Emergency warning: Seek immediate emergency medical care for difficulty breathing, swelling of the face, lips, tongue, or throat, fainting, severe dizziness, widespread hives, chest pain, or other signs of a potentially serious allergic or medical reaction